CASI PHARMACEUTICALS, INC. Redeemable Noncontrolling Interest, Equity, Redemption Value
CASI PHARMACEUTICALS, INC. had Redeemable Noncontrolling Interest, Equity, Redemption Value of $22.36 million as of 2022-12-31, per its 20-F filed 2023-04-26.
Discontinued › Notes
us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue · last filed 2023-04-26
- 2022-12-31: Redeemable Noncontrolling Interest, Equity, Redemption Value $22.36M.
- 2022-09-30: Redeemable Noncontrolling Interest, Equity, Redemption Value $21.50M.
- 2022-06-30: Redeemable Noncontrolling Interest, Equity, Redemption Value $22.66M.
- 2022-03-31: Redeemable Noncontrolling Interest, Equity, Redemption Value $23.73M.
| Period end | Redeemable Noncontrolling Interest, Equity, Redemption Value |
|---|---|
| 2022-12-31 | $22.36M 20-F · filed 2023-04-26 |
| 2022-09-30 | $21.50M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $22.66M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $23.73M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $23.46M 20-F · filed 2023-04-26 |
| 2021-09-30 | $22.91M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $22.70M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $22.16M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $22.03M 10-K · filed 2022-03-28 |
| 2020-09-30 | $21.27M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $21.07M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $20.88M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $20.67M 10-K · filed 2021-03-30 |
| 2019-09-30 | $20.46M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $20.24M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $20.02M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-16 |